Literature DB >> 9521061

DNA immunization in relB-deficient mice discloses a role for dendritic cells in IgM-->IgG1 switch in vivo.

M Gerloni1, D Lo, M Zanetti.   

Abstract

A single intraspleen inoculation of plasmid DNA coding for an immunoglobulin heavy chain gene initiates immunity and establishes immunologic memory against the antigenic determinants of transgenic immunoglobulins, somatic transgene immunization. During priming mice produce IgM but not IgG1 antibodies. Since IgM --> IgG1 class switch occurs spontaneously during the primary immune response to protein antigens we investigated possible mechanisms for failure of spontaneous isotype switch in vivo in this model of immunity. We found that inoculation of plasmid DNA in the form of a chimeric gene coding for granulocyte-macrophage colony-stimulating factor (GM-CSF) was able to drive IgG1 class switch readily after priming. Since GM-CSF activates cells of the dendritic lineage we tested the possibility that dendritic cells (DC) may be involved in regulating IgM --> IgG1 switch. To this end we used bone marrow chimeras constructed from mice carrying the null mutation for the relB member of the NF-kappaB/Rel family as these mice lack bone marrow-derived mature DC. RelB (-/-) mice and (-/-) bone marrow chimeras inoculated with DNA/GM-CSF did not produce IgG1 antibodies during the primary immune response. Since relB (-/-) bone marrow chimeras lack DC of donor origin but possess resident follicular dendritic cells we conclude that Ig class switch in vivo is regulated by the function of interdigitating dendritic cells (IDC). Thus, IDC may contribute to the qualitative aspects of the emerging immune response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521061     DOI: 10.1002/(SICI)1521-4141(199802)28:02<516::AID-IMMU516>3.0.CO;2-M

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

Review 1.  Immune regulation: susceptibility and resistance to autoimmunity.

Authors:  D Lo
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  DBC1 is a suppressor of B cell activation by negatively regulating alternative NF-κB transcriptional activity.

Authors:  Sinyi Kong; Muthusamy Thiruppathi; Quan Qiu; Zhenghong Lin; Hongxin Dong; Eduardo N Chini; Bellur S Prabhakar; Deyu Fang
Journal:  J Immunol       Date:  2014-10-31       Impact factor: 5.422

Review 3.  Immunoregulation of dendritic cells.

Authors:  Mark A Wallet; Pradip Sen; Roland Tisch
Journal:  Clin Med Res       Date:  2005-08

4.  Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms.

Authors:  Carlos G Briseño; Marco Gargaro; Vivek Durai; Jesse T Davidson; Derek J Theisen; David A Anderson; Deborah V Novack; Theresa L Murphy; Kenneth M Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

5.  Anti-Sm B cell tolerance and tolerance loss in systemic lupus erythematosus.

Authors:  Stephen H Clarke
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

6.  Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern.

Authors:  Gonzalo Almanza; Alex E Clark; Valentina Kouznetsova; Eduardo Olmedillas; Andrea Castro; Igor F Tsigelny; Yan Wu; George F Gao; Sandra L Leibel; William Bray; Erica Ollmann Saphire; Aaron F Carlin; Maurizio Zanetti
Journal:  PLoS Pathog       Date:  2022-07-21       Impact factor: 7.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.